Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 6/20 | 0.44 |
| ▸ | CES1 | P23141 | 5/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | BHMT | Q93088 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 4/20 | 0.37 |
| ▸ | PPARD | Q03181 | 4/20 | 0.37 |
| ▸ | PPARA | Q07869 | 4/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL724257 | 0.94 | TSHR (0.48) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL722984 | 0.85 | TSHR (0.59) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL724255 | 0.85 | TDP1 (0.46) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL18832140 | 0.83 | HSD17B10 (0.53) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL723379 | 0.83 | TSHR (0.61) | HSD17B10GMNNTP53POLBMAPT | |
| SCHEMBL18832148 | 0.82 | HSD17B10 (0.57) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL18832128 | 0.82 | HSD17B10 (0.57) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL18832134 | 0.82 | HSD17B10 (0.57) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL18832126 | 0.81 | HSD17B10 (0.45) | CES2CES1HSD17B10GMNNTP53 | |
| SCHEMBL7203254 | 0.81 | GPR84 (0.60) | HSD17B10GMNNTP53POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2550251-B1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL CO (JP) | 2015-04-29 | — | — | EP | disclosed |
| US-8779190-B2 | Process for producing sulfur-containing amino acid or salt thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-2609076-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | Sumitomo Chemical Co., Ltd (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-20130137896-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-30 | — | — | US | disclosed |
| US-20130137897-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-30 | — | — | US | disclosed |
| EP-2550251-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | Sumitomo Chemical Company, Limited (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20130012737-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-10 | — | — | US | disclosed |
| WO-2012081712-A1 | PROCESS FOR THE PREPARATION OF HYDROXYCARBOXYLIC ACID COMPOUND OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012026619-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011118849-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137896-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | HPD, STS, HACL2 | CES2 883/4885CES1 371/4885HSD17B10 78/4885 |
| US-20130137897-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | HPD, STS, HAO2 | CES2 748/4885CES1 529/4885HSD17B10 76/4885 |
| US-20130012737-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | CBS, ASS1, TST | CES2 2997/4885CES1 3364/4885HSD17B10 1711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.